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INTRODUCTION
 Pulmonary inflammatory pseudotumor is a relatively 
rare benign tumor located in the lungs but could occur in 
the mesentry, greater omentum, liver, bladder and upper 
respiratory tract. Most of the patients are under 40 years 
of age and complain mainly of non-specific symptoms. 
Lesions are shown as pulmonary nodules or masses 
in which the border can be characteristically well 
distinguished on X-ray. Diagnosis of this tumor is difficult 
without surgical biopsy or resection. It is principally 
treated with surgery. This tumor was reported as fibrous 
histiocytoma, plasma cell granuloma and inflammatory 
pseudotumor in Korea. A total of 27 cases of pulmonary 
inflammatory pseudotumor have been reported in Korea, 
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including 3 cases reported from Severance Hospital, until 
January 2001. However, most of the cases were simple 
case reports so that comprehensive discussion on 
pulmonary inflammatory pseudotumor was not enough 
in those series. Thus, we conducted a review of the 
literature on pulmonary inflammatory pseudotumor, 
including a case that we recently experienced, to 
examine the clinical features, diagnosis and treatment of 
this disease.
MATERIALS AND METHODS
1. Materials
  We collected 28 cases of pulmonary inflammatory 
pseudotumor in Korea, including 4 cases that we experi-
enced at the Severance Hospital, and supplemented 
from the literature reported as fibrous histiocytoma, 
plasma cell granuloma and inflammatory pseudotumor 
since 1977.
2. Methods
  Through the review of the literature, we collected the 
patients’ data, including age, gender, chief complaint, 
hematologic examination, size and location of the lesion, 
cavity formation, presence of calcification and treatment 
method. Referring to the studies already published, 
some items were not available for each case2, 8, 10, 12, 14). 
Figure 1. 52-year-old man with pulmonary inflamma-
tory pseudotumor. The chest radiograph showed a huge 
mass-like density in the left upper and lower lung fields.
Information for the gender of the patient could be 
confirmed in 27 cases, that for the age in 20 cases, and 
that for the clinical pattern in 27 cases. Hematologic 
findings were described in 15 cases. Size of the lesion 
could be determined in 21 cases. Radiographic or path-
ologic findings were described in 27 cases. Diagnostic 
method could be confirmed in 28 cases and treatment 
method in 27 cases.
Figure 2. The chest CT scan showed a huge mass in the 
posterior segment of left upper lobe and the superior 
segment of left lobe. It disclosed the multiple cavitary or 
cystic lesions and air bronchograms.
Figure 3. The chest CT scan showed a huge mass in the 
posterior segment of left upper lobe and the superior 
segment of left lobe. It disclosed the multiple cavitary or 
cystic lesions and air bronchograms.
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RESULTS
  The cases of pulmonary inflammatory pseudotumor 
reported in Korea are summarized in Table 1. Male was
Table 1. Summary of Features of Pulmonary Inflammatory Pseudotumors in Korea
Authors Sex Age
(yr)
Chief complaint Hematologicexam Size, location of mass Cavitation Calcification Treatment
Lee
et al1)
M 29 dyspnea, chest pain neutropenia 4×2.5 cm, RUL*
7×6 cm, RML
no no bilobectomy
Kwak 
et al2)
F 31 general weakness,
headache
anemia 6.5×7.5 cm, LML no no lobectomy
Kim
et al3)
M 17 hemoptysis,
dyspnea
not described 1.5×1.5×1.2 cm,
trachea
no no bronchoscopic removal
Yoo
et al4)
M 33 dyspnea on exertion,
cough
normal 1.5 cm, endobronchus
of left main
no no pneumonectomy
Chong
et al5)
F 44 chest pain anemia not described,
RML and RLL
no no pneumonectomy
M 30 dry cough normal diameter 2.5 cm, LLL no no lobectomy
Lee
et al6)
F 24 cough, fever normal 4×4 cm, RLL no no lobectomy
F 46 hemoptysis normal not described, LUL no no lobectomy,
recurred
Ryoo 
et al7)
M 17 chest discomfort,
cough
normal 5.5×6.0 cm, RUL no yes lobectomy 
Kim
et al8)
M 55 hemoptysis, cough,
chest pain
not described 5×5 cm, RML no yes lobectomy
M 31 fever, chill, chest pain not described 5×4 cm, LLL yes no lobectomy
M 58 cough, sputum not described 5×7 cm, RUL no no lobectomy
Park
et al9)
M 6 cough, fever thrombocytopenia not described, RML no no lobectomy
Park
et al10)
- - bronchiectasis not described not described, LLL - - lobectomy
Bang 
et al11)
M 58 sputum eosinophilia 6.0×3.3 cm, 3.0×2.5 cm, 
LLL,
2.8×2.4 cm, LUL, 
3.2×2.5 cm, 1.6×1.2 cm,
RLL
no no steroid therapy
Chae
et al12)
M 37 fever, chill,
cough
not described 2×1.5×0.5 cm,
endobronchus of LLL
no no segmentectomy 
Jeon
et al13)
M 61 dyspnea on exertion,  
chest pain
leukocytosis, 
anemia
not described,
left lung
no yes pneumonectomy
Kim
et al14)
M - right lower 
chest pain
not described 5 cm, RLL no no wedge resection
M - incidentally
discovered
not described 2 cm, RML no no wedge resection
M - incidentally
discovered
not described 3 cm, RUL no no wedge resection
M - incidentally
discovered
not described 3 cm, RUL no no lobectomy
M - intermittent
chest pain
not described 4 cm, LLL no no lobectomy
M - blood tinged sputum
productive cough
not described 6 cm, LUL no no lobectomy
M - cough,
purulent sputum
not described not described,
RUL, RLL, and LLL
yes no not described
Kim
et al15)
M 46 right upper quadrant
pain
normal 5.0×4.0 cm,
RUL
no no wedge resection
F 20 dyspnea, cough,
sputum
normal not described, endobronchus
of right main
no yes lobectomy
Choi 
et al16)
M 63 intermittent fever elevated ESR 3 cm, LUL no yes spontaneous regression
Kim
et al**
M 52 fever, cough,
hemoptysis
normal 7×7×14 cm,
LUL and LLL
yes no steroid therapy
*  Abbreviations: RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe
** Author's case recently experienced in Severance Hospital
more prevalent than female in 22 out of 27 cases 
(81.5%) and the mean age was 37.9 years old (range: 
6∼63 yrs).
  As for the clinical features, a majority of the patients, 
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12 cases (44.4%) out of 27 cases, complained of cough, 
followed by chest pain in 8 cases (29.6%), fever in 6 
cases (22.2%), hemoptysis and sputum in 4 cases (15%), 
respectively, and dyspnea in 3 cases (11.1%). Other 
symptoms, including dyspnea on exertion, general 
weakness, headache, upper abdominal pain and blood 
tinged sputum, were present in one case, respectively. 
Respiratory symptoms were present in 22 cases (78.6%) 
out of 28 cases at the time of diagnosis. Three cases 
(11.1%) were asymptomatic.
  Among those 15 cases in which the hematologic 
findings could be determined, there was normal finding 
in 8 cases (53.3%), anemia in 3 cases (20%) and 
neutropenia, thrombocytopenia, eosinophilia, leukocytosis, 
elevated ESR in one case, respectively (6.7%). Leuko-
cytosis was observed together with anemia in one 
case13).
  Based on the longest diameter, the average size of 
the lesion was 4.8 cm (1.5∼14 cm). As for the location of 
the lesion in 28 cases, there was lung parenchymal 
lesion in 24 cases (85.7%), endobronchial lesion in 3 cases 
(10.7%) and endotracheal lesion in 1 case (3.6%). Other 
than the endotracheal lesion, the lesion was in the right 
side in 13 cases (46.4%), in the left side in 12 cases 
(42.8%) and bilateral in 2 cases (7.1%).
  In 27 cases with radiographic or pathologic findings 
stated, calcification was seen in 5 cases (18.5%)7, 8, 13, 15, 16) 
and cavity formation was seen in 3 cases (11.1%)8, 14).
  As for the diagnostic methods, the open thoracotomy 
was the most prevalent with 23 cases (82.1%) out of 
28 cases; among these 23 cases, one case was diag-
nosed accidentally after the patient underwent left lower 
lobectomy due to bronchiectasis. Otherwise, the tumor 
was totally removed using a bronchoscope in 1 case 
(3.6%)3), and was diagnosed through percutaneous fine 
needle aspiration (FNA) biopsy in 2 cases (7.1%)11, 16) 
and core needle gun biopsy in 2 cases (7.1%)14).
  As for treatment, thoracotomy was performed in 23 
cases (85.2%) out of 27 cases. Rigid bronchoscopic 
removal was performed in 1 case (3.7%)3). Prednisolone 
therapy was done in 2 cases (7.4%) out of 27 cases; in 
one case, a daily dose of 15 mg was given for 45 days 
with tapering11). We used 20 mg of prednisolone on the 
first day and tapered it within the 6 month treatment 
period. One case (3.7%) showed improvement with the 
lesion being decreased and symptoms improved with 
conservative treatment16). Recurrence after surgery was 
reported in 1 case (4.3%)6) out of 23 cases.
DISCUSSION
  As a relatively rare benign disease, the rate of 
inflammatory pseudotumor located in the lung is 0.7% of 
all tumors developing in the lung parenchyma and 
bronchus17) and the rate of tumor development within the 
bronchus is 6.6% of pulmonary inflammatory pseudo-
tumor18) According to the study by Park et al.10) in 1992, 
only one case (3.3%) of inflammatory pseudotumor was 
seen out of 30 cases of benign lung tumors. No gender 
difference was known to be present and more than a 
half of the patients were under 40 years of age and 15% 
of those patients were between the ages of 1∼10 
years18, 19) In this study, 81.5% of the cases were male, 
55% of them were under 40 years of age, and 1 case 
was a child under 6 years of age9).
  Pulmonary inflammatory pseudotumor is considered as 
an inflammatory or reactive lesion rather than neoplasm, 
and about 30% of the patients had a past history of 
respiratory infection20, 21). Although the cause of this 
disease has not been determined accurately, inflam-
matory lesions are thought to occur locally as a result of 
excessive response to tissue damages22).
  About 60∼70% of the patients complained of cough, 
fever, dyspnea and chest pain23). The results of the 
present study showed that the symptoms were present 
in 24 cases (88.9%) out of 27 cases. The asymp-
tomatic 3 cases were incidentally noted by chest X-ray 
abnormality14).
  Laboratory findings were usually within the normal 
ranges and some could show thrombosytosis, elevated 
ESR and multiclonal hypergammaglobuminemia24).
  Characteristic findings of chest X-ray revealed a 
solitary, peripheral, sharply circumscribed and lobulated 
mass25). Those cases with the lesions developed in the 
bronchus can show obstructive pneumonia or findings 
of atelectasis, can spread into the lung hilum or 
mediastinum and rarely accompany pleural effusion25). 
Calcification is seen with larger lesions20) and lesions are 
known to form a cavity rarely25). Although calcification 
was reported in 5 cases in Korea7, 8, 13, 15, 16), it was not 
related with the size of the lesion. Cavity formation could 
be seen in 3 cases8, 14).
  On gross examination of pulmonary inflammatory 
pseudotumor, a single oval intrapulmonary mass can be 
demarcated well, it shows golden-brown or red-brown 
color with no capsule and it is hard in consistency.  
It can show hemorrhage, necrosis or micro-calcification 
deposit19, 25). Histologically, mature plasma cells are the 
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major component of the mass, and fibroblasts, gelatinous 
substance and, characteristically, the Russel bodies are 
scattered in palisade or axel form within the hyaline 
material19). According to histological characteristic, it is 
distinguished into plasma cell granuloma and histiocy-
toma. The former form is composed of fibroblast, myo-
fibroblast, collagen and inflammatory cells, and has 
spindle cells in long and short bundles20). In the latter 
form, collagen, spindle cells and macrophages are 
arranged in a whirlpool form and osteodysplasia and 
calcification can be present21). However, these two are 
considered to be the same disease since many 
pathologic findings are repeated and they are clinically 
very similar26).
Figure 4. Microscopic findings of the biopsy specimen 
showed dense lymphoplasmacytic infiltration within fibrotic 
stroma. (H&E stain, X 40)
Figure 5. Microscopic findings of the biopsy specimen 
showed dense lymphoplasmacytic infiltration within fibrotic 
stroma. (H&E stain, X 200)
Figure 6. Twelve months later, the follow-up chest 
radiograph with the use of prednisolone revealed a 
marked-size reduction of the mass.
  Since the findings of inflammation and fibrosis seen 
in pulmonary inflammatory pseudotumor can be found 
around the lesion of lung cancer as a reactive response, 
FNA biopsy may not be an appropriate method of 
diagnosing inflammatory pseudotumor21). However, the 
diagnosis of pulmonary inflammatory pseudotumor may 
be suggested if the combination of a localized density on 
a chest X-ray and the FNA cytologic findings an taken 
into account27). Therefore, repeated FNA biopsy can be 
recommended for diagnosis28). It was reported that a 
higher accuracy rate can be obtained using core 
needle gun biopsy compared with FNA biopsy in chest 
lesions29). Other than pathologic diagnosis after surgery, 
the diagnosis was made with percutaneous FNA biopsy 
in 2 cases and with core needle gun biopsy in 2 cases 
in Korea. However, since the findings of pulmonary inflam-
matory pseudotumor are non-specific and the disease is 
not distinguished well from lung cancer or metastatic 
cancer, the diagnosis of this disease before surgery is 
rare. Pulmonary inflammatory pseudotumor needs to 
be distinguished from sclerosing hemangioma, pseud-
olymphoma and malignant sarcoma12).
  Surgery is the treatment of choice in pulmonary inflam-
matory pseudotumor to distinguish between malignant 
tumors18, 19, 22, 23). Among 27 cases in which surgery was 
performed, thoracotomy was performed in 23 cases 
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and removal of the tumor using a bronchoscope was 
performed in 1 case. Recurrence is reported to be rare18). 
Only one case of recurrence was reported in Korea 
from the authors’ affiliated hospital6). The inflammatory 
pseudotumor recurred in the meninges after 10 years 
and was treated with corticosteroids for 6 years. The 
follow-up periods were not long and the recurrence 
might be underestimated even in the world literature 
because the information from the review of the literature 
were collected at the time of the report. When lesions 
were impossible to remove surgically or not removed 
completely, steroid therapy11, 24, 30) or radiation therapy31) 
were also performed. There was a report that oral 
prednisolone at the dose of 2 mg/kg/d for 15 weeks 
reduced the size of lung infiltration24). Oral steroid 
could be administered in recurred cases after the 
surgery30). There was a complete disappearance of the 
mass on chest X-ray with 15 mg/d of prednisolone for 
45 days in a Korean report11). We observed the 
disappearance of the mass on serial chest X-ray and 
symptomatic improvement with the administration of 
prednisolone started from 20 mg/d, then tapered for 6 
months; no signs of recurrence were seen during the 12 
month follow-up. There was a case in which the lesion 
was decreased and symptoms improved with no specific 
treatment.
  In conclusion, pulmonary inflammatory pseudotumor 
was more prevalent in the male and patients presenting 
with the respiratory symptoms were common. It was 
necessary to do surgery in most cases for the diagnosis 
and/or treatment.
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